Segment and Related Information (Tables)

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Summary of financial information concerning the Company's reporting segments

	Patient Care						Products & Services
	For the Year Ended December 31,						For the Year Ended December 31,
(in thousands)	2021		2020		2019		2021		2020		2019
Net revenue
Third party	$	943,328	$	831,603	$	905,691	$	177,160	$	169,547	$	192,355
Intersegments	—		—		—		220,792		189,604		203,496
Total net revenue	943,328		831,603		905,691		397,952		359,151		395,851
Material costs
Third party suppliers	248,961		221,566		250,407		105,381		93,844		107,364
Intersegments	38,243		25,818		24,394		182,549		163,786		179,102
Total material costs	287,204		247,384		274,801		287,930		257,630		286,466
Personnel expenses	339,578		302,206		319,633		57,996		48,985		52,592
Other expenses	152,947		115,924		151,140		26,951		24,638		28,178
Depreciation & amortization	19,622		18,892		18,541		7,860		10,173		10,650
Segment income from operations	$	143,977	$	147,197	$	141,576	$	17,215	$	17,725	$	17,965
Purchase of property, plant and equipment	$	10,242	$	10,607	$	16,102	$	9,215	$	11,040	$	2,368
Purchase of therapeutic program equipment leased to third parties under operating leases	$	—	$	—	$	—	$	2,280	$	3,592	$	6,672

Schedule of reconciliation of reportable segments

A reconciliation of the total of the reportable segment’s income (loss) from operations to consolidated income from operations is as follows:

(in thousands)	2021		2020		2019
Income from operations
Patient Care	$	143,977	$	147,197	$	141,576
Products & Services	17,215		17,725		17,965
Corporate & other	(88,521)		(93,015)		(94,113)
Income from operations	72,671		71,907		65,428
Interest expense, net	28,864		32,445		34,258
Non-service defined benefit plan expense	667		632		691
Income before income taxes	43,140		38,830		30,479
Provision for income taxes	1,158		638		2,954
Net income	$	41,982	$	38,192	$	27,525

A reconciliation of the reportable segment’s net revenue (loss) to consolidated net revenue is as follows:

(in thousands)	2021		2020		2019
Net Revenue
Patient Care	$	943,328	$	831,603	$	905,691
Products & Services	397,952		359,151		395,851
Corporate & other	—		—		—
Consolidating adjustments	(220,792)		(189,604)		(203,496)
Consolidated net revenue	$	1,120,488	$	1,001,150	$	1,098,046

A reconciliation of the reportable segment’s material costs to consolidated material costs is as follows:

(in thousands)	2021		2020		2019
Material costs
Patient Care	$	287,204	$	247,384	$	274,801
Products & Services	287,930		257,630		286,466
Corporate & other	—		—		—
Consolidating adjustments	(220,792)		(189,604)		(203,496)
Consolidated material costs	$	354,342	$	315,410	$	357,771

A reconciliation of the reportable segment’s purchase of property, plant and equipment to consolidated purchase of property, plant and equipment, including purchases of therapeutic program equipment leased to third parties under operating leases, is as follows:

(in thousands)	2021		2020		2019
Purchase of property, plant and equipment and therapeutic program equipment leased to third parties under operating leases
Patient Care	$	10,242	$	10,607	$	16,102
Products & Services
Property, plant and equipment	9,215		11,040		2,368
Therapeutic program equipment leased to third parties under operating leases	2,280		3,592		6,672
Corporate & other	3,122		2,853		7,963
Total consolidated purchase of property, plant and equipment and therapeutic program equipment leased to third parties under operating leases	$	24,859	$	28,092	$	33,105

A reconciliation of the total of the reportable segment’s assets to consolidated assets is as follows:

(in thousands)	2021		2020
Assets
Patient Care	$	705,614	$	578,319
Products & Services	133,075		121,564
Corporate & other	159,450		250,868
Total consolidated assets	$	998,139	$	950,751